{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:50:25Z","timestamp":1758361825178,"version":"3.44.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["U01 ES028184"],"award-info":[{"award-number":["U01 ES028184"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"name":"COBRE Pilot"},{"name":"National Institution of Health"},{"name":"National Institution of General Medical Sciences","award":["P30GM149398"],"award-info":[{"award-number":["P30GM149398"]}]},{"name":"Brown University Biomedical Innovation to Impact"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are a promising new approach for in vitro proarrhythmic cardiotoxicity assessment. However, variation due to differentiation batch, individual sample variation, and non-linear responses to test drugs complicate the prediction of proarrhythmic drug concentrations. This study combines a computational human action potential (AP) model of hERG channel block with experimental data from three-dimensional hiPSC-CM engineered microtissues to optimize point of departure (POD) estimation of drug-induced prolongation of AP duration (APD). Computer simulations predicted that APD prolongation from hERG block follows a logistic curve and that &amp;gt;81% hERG block induced early afterdepolarizations (EADs), which significantly shifted the APD response curve. Curve fitting of APD response by logistic, bilinear breakpoint, and maximal curvature was more accurate prior to EAD onset. Goodness-of-fit testing indicated that logistic regression with \u22656 test concentrations was sufficient to accurately estimate PODs. Power analysis, based on experimental variations between batches (n\u2009=\u200914), molds (n\u2009=\u200957), and microtissues (n\u2009=\u20091701), predicted that PODs from 2\u2009\u223c\u20093 batches with 10 microtissues per mold using a 5% threshold for APD prolongation detected proarrhythmic cardiotoxicity with a negligible false positive rate. We then applied this POD analysis to hiPSC-CM microtissue data after treatment with well-characterized drugs (i.e. cisapride, ranolazine, quinidine, and verapamil). Using bootstrapping, we estimated PODs and confidence intervals that matched concentrations known to cause proarrhythmic effects in patients. This study identified a robust method for calculating PODs for proarrhythmic cardiotoxicity risk in vitro and developed a framework for experimental design in this and other in vitro platforms.<\/jats:p>","DOI":"10.1093\/toxsci\/kfaf094","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T11:57:50Z","timestamp":1752926270000},"page":"221-237","source":"Crossref","is-referenced-by-count":0,"title":["Computationally informed point of departure evaluation for proarrhythmic cardiotoxicity assessment using 3D engineered cardiac microtissues from human iPSC-derived cardiomyocytes"],"prefix":"10.1093","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7236-5215","authenticated-orcid":false,"given":"Mark C","family":"Daley","sequence":"first","affiliation":[{"name":"Center for Biomedical Engineering, Brown University , Providence, RI 02912,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bronk","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Rhode Island Hospital and Warren Alpert Medical School of Brown University , Providence, RI 02903,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Yun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Physics, Korea University , Seoul, 02841,","place":["Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvin H","family":"Soepriatna","sequence":"additional","affiliation":[{"name":"Center for Biomedical Engineering, Brown University , Providence, RI 02912,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cao T","family":"Tran","sequence":"additional","affiliation":[{"name":"Cardiovascular Institute, Rhode Island Hospital , Providence, RI 02903,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Mende","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Rhode Island Hospital and Warren Alpert Medical School of Brown University , Providence, RI 02903,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kareen L K","family":"Coulombe","sequence":"additional","affiliation":[{"name":"Center for Biomedical Engineering, Brown University , Providence, RI 02912,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bum-Rak","family":"Choi","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Rhode Island Hospital and Warren Alpert Medical School of Brown University , Providence, RI 02903,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"2025091914023380000_kfaf094-B1","doi-asserted-by":"crossref","first-page":"H180","DOI":"10.1152\/ajpheart.00944.2005","article-title":"Short-term cardiac memory and mother rotor fibrillation","volume":"292","author":"Baher","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025091914023380000_kfaf094-B2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/2472555220953207","article-title":"Assessment of drug proarrhythmic potential in electrically paced human induced pluripotent stem cell-derived ventricular cardiomyocytes using multielectrode array","volume":"26","author":"Bai","year":"2021","journal-title":"SLAS Discov"},{"key":"2025091914023380000_kfaf094-B3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/toxsci\/kfaa151","article-title":"A Bayesian method for population-wide cardiotoxicity hazard and risk characterization using an in vitro human model","volume":"178","author":"Blanchette","year":"2020","journal-title":"Toxicol Sci"},{"key":"2025091914023380000_kfaf094-B4","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.celrep.2018.08.079","article-title":"International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment","volume":"24","author":"Blinova","year":"2018","journal-title":"Cell Rep"},{"key":"2025091914023380000_kfaf094-B5","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/17425255.2021.1894122","article-title":"Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk characterization","volume":"17","author":"Burnett","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2025091914023380000_kfaf094-B6","first-page":"21.3.1","article-title":"Chemically defined culture and cardiomyocyte differentiation of human pluripotent stem cells","volume":"87","author":"Burridge","year":"2015","journal-title":"Curr Protoc Hum Genet"},{"key":"2025091914023380000_kfaf094-B7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrcardio.2016.36","article-title":"Induced pluripotent stem cells: at the heart of cardiovascular precision medicine","volume":"13","author":"Chen","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"2025091914023380000_kfaf094-B8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vascn.2016.06.002","article-title":"The comprehensive in vitro proarrhythmia assay (CiPA) initiative\u2014update on progress","volume":"81","author":"Colatsky","year":"2016","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2025091914023380000_kfaf094-B9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/toxsci\/kfae079","article-title":"In vitro to in vivo extrapolation from three-dimensional hiPSC-derived cardiac microtissues and physiologically based pharmacokinetic modeling to inform next-generation arrhythmia risk assessment","volume":"201","author":"Daley","year":"2024","journal-title":"Toxicol Sci"},{"key":"2025091914023380000_kfaf094-B10","first-page":"103","article-title":"Beyond pharmaceuticals: fit-for-purpose new approach methodologies for environmental cardiotoxicity testing","volume":"40","author":"Daley","year":"2023","journal-title":"ALTEX"},{"key":"2025091914023380000_kfaf094-B11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1476-5381.2009.00487.x","article-title":"The thorough QT\/QTc study 4 years after the implementation of the ICH e14 guidance","volume":"159","author":"Darpo","year":"2010","journal-title":"Br J Pharmacol"},{"key":"2025091914023380000_kfaf094-B12","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1161\/01.CIR.90.3.1469","article-title":"Optical mapping of repolarization and refractoriness from intact hearts","volume":"90","author":"Efimov","year":"1994","journal-title":"Circulation"},{"key":"2025091914023380000_kfaf094-B13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrd.2015.34","article-title":"Evolution of strategies to improve preclinical cardiac safety testing","volume":"15","author":"Gintant","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"2025091914023380000_kfaf094-B14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/toxsci\/kft113","article-title":"Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays","volume":"134","author":"Harris","year":"2013","journal-title":"Toxicol Sci"},{"key":"2025091914023380000_kfaf094-B15","doi-asserted-by":"crossref","first-page":"11893","DOI":"10.1038\/s41598-019-48174-5","article-title":"Novel method for action potential measurements from intact cardiac monolayers with multiwell microelectrode array technology","volume":"9","author":"Hayes","year":"2019","journal-title":"Sci Rep"},{"key":"2025091914023380000_kfaf094-B16","first-page":"25","article-title":"Evaluation of batch variations in induced pluripotent stem cell-derived human cardiomyocytes from 2 major suppliers","volume":"156","author":"Huo","year":"2017","journal-title":"Toxicol Sci"},{"year":"2006","author":"International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). Food and Drug Administration.","key":"2025091914023380000_kfaf094-B17"},{"key":"2025091914023380000_kfaf094-B18","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1111\/risa.13324","article-title":"A review of recent advances in benchmark dose methodology","volume":"39","author":"Jensen","year":"2019","journal-title":"Risk Anal"},{"key":"2025091914023380000_kfaf094-B19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jelectrocard.2010.02.006","article-title":"Heterogeneous memory in restitution of action potential duration in pig ventricles","volume":"43","author":"Jing","year":"2010","journal-title":"J Electrocardiol"},{"key":"2025091914023380000_kfaf094-B20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.vascn.2015.12.002","article-title":"CSAHi study: evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia\u2014effects of 7 reference compounds at 10 facilities","volume":"78","author":"Kitaguchi","year":"2016","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2025091914023380000_kfaf094-B21","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1038\/s41598-021-89478-9","article-title":"A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues","volume":"11","author":"Kofron","year":"2021","journal-title":"Sci Rep"},{"key":"2025091914023380000_kfaf094-B22","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bph.16250","article-title":"The impact of uncertainty in herg binding mechanism on in silico predictions of drug-induced proarrhythmic risk","volume":"181","author":"Lei","year":"2024","journal-title":"Br J Pharmacol"},{"key":"2025091914023380000_kfaf094-B23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10928-018-9582-0","article-title":"Assessing QT\/QTc interval prolongation with concentration-QT modeling for Phase I studies: impact of computational platforms, model structures and confidence interval calculation methods","volume":"45","author":"Lu","year":"2018","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"2025091914023380000_kfaf094-B24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev-pharmtox-010617-053110","article-title":"Human induced pluripotent stem cell (hiPSC)-derived cells to assess drug cardiotoxicity: opportunities and problems","volume":"58","author":"Magdy","year":"2018","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2025091914023380000_kfaf094-B25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCEP.112.970491","article-title":"Repolarization changes underlying long-term cardiac memory due to right ventricular pacing: noninvasive mapping with electrocardiographic imaging","volume":"5","author":"Marrus","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025091914023380000_kfaf094-B26","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1254\/jphs.13248FP","article-title":"Assessment of testing methods for drug-induced repolarization delay and arrhythmias in an iPS cell-derived cardiomyocyte sheet: multi-site validation study","volume":"124","author":"Nakamura","year":"2014","journal-title":"J Pharmacol Sci"},{"key":"2025091914023380000_kfaf094-B27","doi-asserted-by":"crossref","first-page":"e1002061","DOI":"10.1371\/journal.pcbi.1002061","article-title":"Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation","volume":"7","author":"O'Hara","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"2025091914023380000_kfaf094-B28","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1007\/s10439-013-0833-3","article-title":"Computational models of ventricular- and atrial-like human induced pluripotent stem cell derived cardiomyocytes","volume":"41","author":"Paci","year":"2013","journal-title":"Ann Biomed Eng"},{"key":"2025091914023380000_kfaf094-B29","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1111\/bph.13282","article-title":"Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block","volume":"172","author":"Paci","year":"2015","journal-title":"Br J Pharmacol"},{"key":"2025091914023380000_kfaf094-B30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.12793\/tcp.2019.27.1.12","article-title":"Introduction to in silico model for proarrhythmic risk assessment under the cipa initiative","volume":"27","author":"Park","year":"2019","journal-title":"Transl Clin Pharmacol"},{"key":"2025091914023380000_kfaf094-B31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.vascn.2016.04.007","article-title":"Specific prediction of clinical QT prolongation by kinetic image cytometry in human stem cell derived cardiomyocytes","volume":"81","author":"Pfeiffer","year":"2016","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2025091914023380000_kfaf094-B32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ahj.2013.11.004","article-title":"Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the cardiac safety research consortium","volume":"167","author":"Sager","year":"2014","journal-title":"Am Heart J"},{"key":"2025091914023380000_kfaf094-B33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/jat.1298","article-title":"The current state of knowledge on the use of the benchmark dose concept in risk assessment","volume":"28","author":"Sand","year":"2008","journal-title":"J of Applied Toxicology"},{"key":"2025091914023380000_kfaf094-B34","doi-asserted-by":"crossref","first-page":"e0280406","DOI":"10.1371\/journal.pone.0280406","article-title":"Action potential metrics and automated data analysis pipeline for cardiotoxicity testing using optically mapped hipsc-derived 3d cardiac microtissues","volume":"18","author":"Soepriatna","year":"2023","journal-title":"PLoS One"},{"key":"2025091914023380000_kfaf094-B35","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jelectrocard.2012.07.020","article-title":"Practice and challenges of thorough QT studies","volume":"45","author":"Stockbridge","year":"2012","journal-title":"J Electrocardiol"},{"key":"2025091914023380000_kfaf094-B36","doi-asserted-by":"crossref","first-page":"e48890","DOI":"10.7554\/eLife.48890","article-title":"Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block","volume":"8","author":"Tomek","year":"2019","journal-title":"Elife"},{"key":"2025091914023380000_kfaf094-B37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.yrtph.2005.07.003","article-title":"The role of the benchmark dose in a regulatory context","volume":"43","author":"Travis","year":"2005","journal-title":"Regul Toxicol Pharmacol"},{"key":"2025091914023380000_kfaf094-B38","doi-asserted-by":"crossref","first-page":"e0167348","DOI":"10.1371\/journal.pone.0167348","article-title":"Electrophysiological characteristics of human iPSC-derived cardiomyocytes for the assessment of drug-induced proarrhythmic potential","volume":"11","author":"Yamamoto","year":"2016","journal-title":"PLoS One"},{"key":"2025091914023380000_kfaf094-B39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/toxsci\/kfac095","article-title":"Use of human iPSC-CMs in nonclinical regulatory studies for cardiac safety assessment","volume":"190","author":"Yang","year":"2022","journal-title":"Toxicol Sci"},{"key":"2025091914023380000_kfaf094-B40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fcvm.2019.00087","article-title":"3D cardiac cell culture: a critical review of current technologies and applications","volume":"6","author":"Zuppinger","year":"2019","journal-title":"Front Cardiovasc Med"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/toxsci\/advance-article-pdf\/doi\/10.1093\/toxsci\/kfaf094\/63814431\/kfaf094.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/toxsci\/article-pdf\/207\/1\/221\/63814431\/kfaf094.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/toxsci\/article-pdf\/207\/1\/221\/63814431\/kfaf094.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T18:02:46Z","timestamp":1758304966000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/207\/1\/221\/8210081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,7,21]]},"published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfaf094","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"type":"print","value":"1096-6080"},{"type":"electronic","value":"1096-0929"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,7,21]]}}}